Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis

References

• Amini Y, Tebianian M, Mosavari N, Fasihi Ramandi M, Ebrahimi SM, Najminejad H, et al. 2016. Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen. Artif Cells Blood Substit Immobil Biotechnol. 1–6.
   Google Scholar
• Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. 2000. ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis. Infect Immun. 68:791–795.
   PubMed Web of Science ®Google Scholar
• Brito LA, O'Hagan DT. 2014. Designing and building the next generation of improved vaccine adjuvants. J Control Release. 190:563–579.
   PubMed Web of Science ®Google Scholar
• da Costa AC, de Oliveira Costa-Junior A, de Oliveira FM, Nogueira SV, Rosa JD, Resende DP, et al. 2014. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis. PLoS One. 9:e112848.
   PubMed Web of Science ®Google Scholar
• Glaziou P, Sismanidis C, Floyd K, Raviglione M. 2015. Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med. 5:a017798.
   Web of Science ®Google Scholar
• He P, Lu F, Chen Y, Zuo G, Li Y, He F. 2005. Synthesis of nanoparticulate alum adjuvant and its application to the HBsAg and rabies virus. J Immunol. 22:90–93.
   Google Scholar
• He P, Zou Y, Hu Z. 2015. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum Vaccin Immunother. 11:477–488.
   PubMed Web of Science ®Google Scholar
• Kanchan V, Panda AK. 2007. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials. 28:5344–5357.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. 2012. Tuberculosis vaccine development: strength lies in tenacity. Trends Immunol. 33:373–379.
   PubMed Web of Science ®Google Scholar
• Knudsen NPH, Nørskov-Lauritsen S, Dolganov GM, Schoolnik GK, Lindenstrøm T, Andersen P, et al. 2014. Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics. Proc Natl Acad Sci USA. 111:1096–1101.
   PubMed Web of Science ®Google Scholar
• Kool M, Pétrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, et al. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 181:3755–3759.
   PubMed Web of Science ®Google Scholar
• Li H, Nookala S, Re F. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol. 178:5271–5276.
   PubMed Web of Science ®Google Scholar
• Li X, Aldayel AM, Cui Z. 2014. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J Control Release. 173:148–157.
   PubMed Web of Science ®Google Scholar
• Mahmood A, Srivastava S, Tripathi S, Ansari MA, Owais M, Arora A. 2011. Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv. FEBS J. 278:341–353.
   PubMed Web of Science ®Google Scholar
• Nagamoto T, Hattori Y, Takayama K, Maitani Y. 2004. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res. 21:671–674.
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 124:849–863.
   PubMed Web of Science ®Google Scholar
• Sun B, Ji Z, Liao Y-P, Wang M, Wang X, Dong J, et al. 2013. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. ACS Nano. 7:10834–10849.
   PubMed Web of Science ®Google Scholar
• Tang C, Huang X, Yang F, Li M, Fan G, Yue H. 2008. Adjuvant effect of aluminum hydroxide nanoparticles on Newcastle diseases antigen in chichens. Chinese Veterinary Sci. 38:1060–1064.
   Google Scholar
• WHO. 2009. Global Tuberculosis Control 2009. Geneva: World Health Organization.
   Google Scholar
• Yang L, Li W, Kirberger M, Liao W, Ren J. 2016. Design of nanomaterial based systems for novel vaccine development. Biomater Sci. 4:785–802.
   Web of Science ®Google Scholar
• Zuñiga J, Torres-García D, Santos-Mendoza T, Rodriguez-Reyna TS, Granados J, Yunis EJ. 2012. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Develop Immunol. 2012.
   PubMedGoogle Scholar